Company Overview
Management
Board of Directors
Investors
Vision
Protein Optimization
ReCode™ Technology
Site Matters
Intellectual Property
Articles
Current Opportunities
Benefits
Corporate Fact Sheet
Pipeline
Protein Optimization
AMBRX NEWS
Wyeth and Ambrx Form Multi-target Alliance to Leverage Recent Ambrx Biologics Platform Advances
Ambrx and Merck Serono Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance
Clinical Data Show Long-Acting Human Growth Hormone ARX201 is Safe and Well Tolerated
Ambrx Appoints Douglas Axelrod Senior Vice President for Clinical Research and Development
Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
© Copyright 2005-2010 Ambrx, Inc. All rights reserved.
